Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant

. 2023 Jun ; 23 (6) : 655-656. [epub] 20230503

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu dopisy

Perzistentní odkaz   https://www.medvik.cz/link/pmid37148902
Odkazy

PubMed 37148902
PubMed Central PMC10156138
DOI 10.1016/s1473-3099(23)00278-5
PII: S1473-3099(23)00278-5
Knihovny.cz E-zdroje

1st Medical Faculty at Biocev Charles University Vestec Prague Czechia

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; Faculty of Medicine Kobe University Kobe Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; Graduate School of Frontier Sciences The University of Tokyo Kashiwa Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; International Research Center for Infectious Diseases The University of Tokyo Tokyo Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; International Research Center for Infectious Diseases The University of Tokyo Tokyo Japan; International Vaccine Design Center The University of Tokyo Tokyo Japan; The Institute of Medical Science and Graduate School of Medicine The University of Tokyo Tokyo Japan; Graduate School of Frontier Sciences The University of Tokyo Kashiwa Japan; Collaboration Unit for Infection Joint Research Center for Human Retrovirus infection Kumamoto University Kumamoto Japan; CREST Japan Science and Technology Agency Kawaguchi Japan

Division of Systems Virology Department of Microbiology and Immunology The University of Tokyo Tokyo Japan; The Institute of Medical Science and Graduate School of Medicine The University of Tokyo Tokyo Japan

Zobrazit více v PubMed

WHO Tracking SARS-CoV-2 variants. March 30, 2023. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants

Zahradnik J, Marciano S, Shemesh M, et al. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. 2021;6:1188–1198. PubMed

Tamura T, Ito J, Uriu K, et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two omicron subvariants. bioRxiv. 2022 doi: 10.1101/2022.12.27.521986. published online Dec 27. (preprint). PubMed DOI PMC

Smith DJ, Lapedes AS, de Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305:371–376. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...